Literature DB >> 22888478

Up-date on neuro-immune mechanisms involved in allergic and non-allergic rhinitis.

L Van Gerven1, G Boeckxstaens, P Hellings.   

Abstract

Non-allergic rhinitis (NAR) is a common disorder, which can be defined as chronic nasal inflammation, independent of systemic IgE-mediated mechanisms. Symptoms of NAR patients mimic those of allergic rhinitis (AR) patients. However, AR patients can easily be diagnosed with skin prick test or allergen-specific IgE measurements in the serum, whereas NAR patients form a heterogeneous group and are difficult to diagnose because of an extensive list of different phenotypes, all varying in severity, underlying etiology and type of inflammation. Characterization of those phenotypes, mechanisms and management of NAR represents one of the major unmet needs in the field of allergic and non-allergic diseases. This review aims at providing a comprehensive overview of the state of the art in classifying the NAR patients and focuses on the neuro-immune mechanisms involved in allergic and non-allergic rhinitis, including reflections on the pathophysiology and the currently available treatment options.

Entities:  

Mesh:

Year:  2012        PMID: 22888478     DOI: 10.4193/Rhino.11.152

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  13 in total

1.  Denervation of nasal mucosa induced by posterior nasal neurectomy suppresses nasal secretion, not hypersensitivity, in an allergic rhinitis rat model.

Authors:  Hironobu Nishijima; Kenji Kondo; Makiko Toma-Hirano; Shinichi Iwasaki; Shu Kikuta; Chisato Fujimoto; Rumi Ueha; Ryoji Kagoya; Tatsuya Yamasoba
Journal:  Lab Invest       Date:  2016-06-20       Impact factor: 5.662

2.  The cost of rhinitis in the United States: a national insurance claims analysis.

Authors:  Lauren T Roland; Sarah K Wise; Heqiong Wang; Patrick Zhang; Christina Mehta; Joshua M Levy
Journal:  Int Forum Allergy Rhinol       Date:  2020-12-10       Impact factor: 3.858

3.  Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis.

Authors:  Yifan Meng; Hongshuang Lu; Chengshuo Wang; Yang Wang; Na Meng; Ke Yang; Ying Jie; Luo Zhang
Journal:  World Allergy Organ J       Date:  2021-05-09       Impact factor: 4.084

Review 4.  Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management.

Authors:  Dimitri Poddighe; Matteo Gelardi; Amelia Licari; Michele Miraglia Del Giudice; Gian Luigi Marseglia
Journal:  World J Methodol       Date:  2016-12-26

Review 5.  Capsaicin for Rhinitis.

Authors:  Wytske Fokkens; Peter Hellings; Christine Segboer
Journal:  Curr Allergy Asthma Rep       Date:  2016-08       Impact factor: 4.806

6.  Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma.

Authors:  Jef Feijen; Sven F Seys; Brecht Steelant; Dominique M A Bullens; Lieven J Dupont; Maria García-Cruz; Alejandro Jimenez-Chobillón; Désirée Larenas-Linnemann; Laura Van Gerven; Wytske J Fokkens; Ioana Agache; Peter W Hellings
Journal:  World Allergy Organ J       Date:  2020-07-01       Impact factor: 4.084

Review 7.  Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management.

Authors:  C Bachert; J Bousquet; P Hellings
Journal:  Clin Transl Allergy       Date:  2018-06-25       Impact factor: 5.871

8.  Determinants of the Nasal Microbiome: Pilot Study of Effects of Intranasal Medication Use.

Authors:  Vijay R Ramakrishnan; Justin Holt; Leah F Nelson; Diana Ir; Charles E Robertson; Daniel N Frank
Journal:  Allergy Rhinol (Providence)       Date:  2018-08-02

Review 9.  Rhinitis Subtypes, Endotypes, and Definitions.

Authors:  Nikolaos G Papadopoulos; George V Guibas
Journal:  Immunol Allergy Clin North Am       Date:  2016-02-28       Impact factor: 3.479

10.  Endotyping of non-allergic, allergic and mixed rhinitis patients using a broad panel of biomarkers in nasal secretions.

Authors:  Christine L Segboer; Wytske J Fokkens; Ingrid Terreehorst; Cornelis M van Drunen
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.